NewTimeSpace News: Baiyunshan announced on June 10 that its subsidiary, Baiyunshan General Pharmaceutical Factory, has received the Drug Registration Certificate for Cefaclor Sustained-release Tablets (II) approved and issued by the National Medical Products Administration.
NewTimeSpace News: Ying Li Holdings issued a profit warning on June 10. It estimates that the consolidated profit after tax for the year ended March 31, 2026 will decrease by no less than 60% compared with the prior year.
NewTimeSpace News: Luk Fook Holdings issued a positive profit alert on June 10. It expects the profit for the year ended March 31, 2026 to increase by approximately 80% to 90% compared with the same period last year.
NewTimeSpace News: Standard Chartered announced on June 10 the appointment of Tanate Phutrakul as Independent Non-Executive Director, with the appointment taking effect on July 1, 2026.
NewTimeSpace News: AiR Digital Solutions, a technology subsidiary of United Alliance Group, announced that its AI-powered operations management platform has obtained ISO/IEC 27001:2022 certification, covering standards for cybersecurity, data privacy and operational resilience.
NewTimeSpace News: MANULIFE US REIT announced on June 10 that its indirect wholly-owned subsidiary completed the sale of the Figueroa property located in Los Angeles on June 9, 2026 (US time).
NewTimeSpace News: Hbm Holdings Limited (02142.HK) announced that the National Medical Products Administration of China has accepted the Investigational New Drug (IND) application for HBM7004, a novel B7H4xCD3 bispecific antibody for the treatment of advanced solid tumors. Previously, the product's IND application was approved by the U.S. FDA, paving the way for its first-in-human Phase I clinical trial.
NewTimeSpace News: As of 13:08 on June 10, 2026, XPENG-W (09868.HK) weakened in the afternoon session, trading at HK$57.90, down 5.55%. Its Robotaxi equipped with VLA2.0 is undergoing L4 autonomous driving tests on public roads in Guangzhou.
NewTimeSpace News: As of 11:42 on June 10, ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) gained 4.77%, with the latest price at HKD 3.818.
NewTimeSpace (newtimespace.com) News: On June 10, 2026, the robotics concept sector in the Hong Kong stock market weakened. UBTECH (09880.HK) dropped substantially during morning trading. As of 11:21 AM, the company's share price was quoted at HK$110.400, down 5.40%.
NewTimeSpace (newtimespace.com) News: On June 10, 2026, Kuaishou-W (01024.HK) surged substantially during morning trading. As of 10:08 AM, the company's share price was quoted at HK$46.060, up 3.88%, leading the gains in the Hang Seng Tech Index.
NewTimeSpace (newtimespace.com) News, Choice data shows that on June 9, 2026, First Seafront Artificial Intelligence Dynamic Allocation Hybrid Fund-A (001986) and First Seafront Artificial Intelligence Dynamic Allocation Hybrid Fund-C (023286) achieved single-day gains of 7.14% respectively.Over the past three months, First Seafront Artificial Intelligence Dynamic Allocation Hybrid Fund-A (001986.OF) and Mixed C (023286.OF) have surged by 64.67% and 64.51% respectively.
NewTimeSpace (newtimespace.com) News, June 09, 2026, OCEAN ONE HLDG(09876.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 426.4 million, increased by 7.71% YoY
Newtimespace (newtimespace.com) reports that Laekna (2105.HK) entered into an exclusive license agreement with Vasque Bio on June 9, 2026, granting Vasque Bio exclusive global rights outside Greater China to develop and commercialize LAE118, a novel PI3Kα inhibitor; Laekna will receive USD 10 million upfront, equity up to a high double-digit percentage, milestone payments up to USD 517 million, and tiered royalties, with LAE118 having already received IND approvals from the FDA and China's CDE.
Newtimespace (newtimespace.com) reports that Chinasoft International (0354.HK) announced its wholly-owned subsidiary has entered into high-end AI computing equipment sales agreements with several independent third-party customers with a total contract value of approximately RMB 1 billion, marking an important commercial breakthrough in AI infrastructure business and the formal entry of its high-end computing segment into scaled market deployment.
Newtimespace (newtimespace.com) reports that Duality Biotherapeutics (9606.HK) announced it is currently undergoing tutoring by CITIC Securities for the proposed issuance of RMB-denominated ordinary shares to be listed on the Shanghai Stock Exchange STAR Market, and has passed the tutoring inspection by the Shanghai Bureau of the China Securities Regulatory Commission, with the Company committing to announce further progress in accordance with relevant laws and regulations.
